Market leadership Farmak positions itself as the leading Ukrainian pharmaceutical manufacturer with a broad portfolio of over 450 medicines and a strong track record of reinvestment in development, signaling sustained capacity for new product partnerships and contract manufacturing opportunities.

Global reach Products distributed in 60 countries across EU, Americas, CIS, Middle East and Asia present avenues for international collaboration, regulatory support, and potential co-development or distribution partnerships in new markets.

Financial strength Significant reinvestment (up to 90% of profits) and revenue in the mid-to-upper hundreds of millions position Farmak as a stable customer for large-scale supply agreements, long-term contracts, and capital-intensive R&D collaborations.

Brand and talent Recognition as a top employer and strong internal communications awards indicate focus on workforce quality and employer branding, suggesting opportunities for HR tech, training services, and employee-health and wellness product partnerships.

Strategic investments Recent pre-seed investment in Tayra AI and ongoing innovation initiatives imply openness to strategic tech collaborations, AI-enabled manufacturing, digitalization solutions, and data analytics partnerships to optimize operations and product development.